It's not the risk and reward leaning now to risk that is disappointing.
it is that exciting things have been sprinkled in the near future, it6 that the manufacturing issues had supposedly been resolved and now we find that's not the case and that for the last month the stock has been sold down on news that appears to have been available to some but not the market.
Ann: Updated guidance for PAT-DX1 phase 1 clinical study, page-48
-
- There are more pages in this discussion • 78 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $6.172M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $626 | 206.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 35 | 40042144 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 10614833 | 12 |
View Market Depth
| Last trade - 15.46pm 04/11/2024 (20 minute delay) ? |
| PAB (ASX) Chart |